CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 59 enrolled
Drug / intervention
Detection of circulating tumor cells in blood samplesgenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02345473
NCT02345473N/ACompleted

Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari·observational·Posted Jan 26, 2015·Updated Jan 26, 2015

In Brief

An observational study evaluating Detection of circulating tumor cells in blood samples for Bladder Cancer and Circulating Tumor Cells. Completed, enrolled 59 participants across 1 site.

Detailed Summary

Very few factors may be identified as prognostic for patients with bladder cancer undergoing radical cystectomy. Recently, detection of circulating tumor cells has shown to be very promising in anticipating both the likelyhood of distant metastases and survival in patients with breast cancer, melanoma, prostate cancer and other malignancies. In the present study we both tested the detection rate of circulating tumor cells using a PCR based methodology in the peripheral blood of patients undergoing radical cystectomy, and we further correlated our results with their clinical outcome.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 26, 2015
Enrollment StartJan 1, 2005
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 9.8 yearsPosted 11.4 years ago

Interventions

Detection of circulating tumor cells in blood samplesgenetic

Ficoll based isolation of mononuclear cells from the peripheral blood of patients undergoing radical cystectomy, nucleic acids extraction and, finally, PCR based detection of sequences specific to cytokeratins.